APYX - Apyx Medical Corp
3.64
-0.200 -5.495%
Share volume: 43,081
Last Updated: 03-27-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$3.84
-0.20
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-08-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-06-2025 | 03-10-2026 | |
| Assets | |||||||||
| Total Assets | 70.711 M | 65.394 M | 60.721 M | 64.842 M | 60.160 M | 58.188 M | 57.365 M | 66.840 M | |
| Current Assets | 61.926 M | 56.671 M | 52.158 M | 56.440 M | 51.851 M | 49.915 M | 48.788 M | 58.471 M | |
| Inventories | 9.795 M | 9.324 M | 9.000 M | 7.564 M | 7.685 M | 8.192 M | 9.145 M | 8.602 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 37.282 M | 32.678 M | 28.013 M | 31.741 M | 31.011 M | 29.301 M | 25.135 M | 31.740 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 1.779 M | 1.918 M | 1.905 M | 1.987 M | 1.910 M | 2.048 M | 2.390 M | 2.371 M | |
| Other Assets | 7.006 M | 6.805 M | 6.658 M | 6.415 M | 6.399 M | 6.225 M | 6.187 M | 5.998 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 70.711 M | 65.394 M | 60.721 M | 64.842 M | 60.160 M | 58.188 M | 57.365 M | 66.840 M | |
| Total liabilities | 50.251 M | 50.470 M | 49.524 M | 50.507 M | 49.516 M | 50.732 M | 51.285 M | 52.009 M | |
| Total current liabilities | 10.556 M | 10.639 M | 9.555 M | 10.721 M | 9.510 M | 10.566 M | 10.978 M | 11.700 M | |
| Accounts Payable | 2.103 M | 2.348 M | 1.914 M | 2.615 M | 2.305 M | 2.893 M | 3.220 M | 3.058 M | |
| Other liabilities | 5.037 M | 4.932 M | 4.845 M | 4.775 M | 4.685 M | 4.607 M | 4.484 M | 4.410 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 33.406 M | 33.628 M | 33.853 M | 33.893 M | 34.127 M | 34.365 M | 34.607 M | 34.849 M | |
| Other liabilities | 5.037 M | 4.932 M | 4.845 M | 4.775 M | 4.685 M | 4.607 M | 4.484 M | 4.410 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 20.253 M | 14.747 M | 11.041 M | 14.210 M | 10.511 M | 7.253 M | 5.848 M | 14.540 M | |
| Common stock | 82.277 M | 83.327 M | 84.324 M | 92.121 M | 92.572 M | 93.092 M | 93.671 M | 103.662 M | |
| Retained earnings | -62.024 M | -68.580 M | -73.283 M | -77.911 M | -82.061 M | -85.839 M | -87.823 M | -89.122 M |